Concepedia

Publication | Open Access

The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer

87

Citations

21

References

2020

Year

Abstract

<sup>18</sup>F-FDG PET-CT can predict MPR to neoadjuvant sintilimab in resectable non-small cell lung cancer.

References

YearCitations

Page 1